ZEAL stock: buy or sell?

ZEAL stock price: $21.96 -1.08% At close on July 15th, 2019

Updated on:
July 15th, 2019


Zealand Pharma A/S closed today at $21.96 and decreased a lame -1.08%.

Zealand Pharma A\u002FS, a biotech company, engages in the discovery, design, and development of novel peptide-based medicines in Denmark.

Should I buy ZEAL stock?

Trading stocks requires experience and discipline, and your buying and selling decisions must come following a methodology. Having a trading plan helps to make decisions easier, quicker and with less hesitations. There are thousands of trading strategies for you to choose, but at Stocks2.com we prefer those that are simple but successful.

Currently, Zealand Pharma A/S stock doesn't match any of these trading strategies, so our recommendation is not to buy.

Buy setupElegible
New all-time highNo
New 52 week highNo
Price crossing up 200d MANo
100d MA crossing up 200d MANo
This is not a selling recommendation at all, just it's not the best moment to buy if you follow any of these trading strategies.

Is Zealand Pharma A/S stock a buy?

Everyday, hundreds of stock ratings are published by financial analysts to indicate a particular stock's attractiveness. At Stocks2.com, we found 1 rating published for ZEAL stock in the last month.

Is ZEAL a good stock to buy?
DateAnalyst / BrokerPrevious ratingCurrent rating
2019-3-7Needham & Company LLCn/aBuy

ZEAL stock analysis

Daily outlook

Shares of Zealand Pharma A/S ended today at $21.96 and decreased a lame -1.08%.

Zealand Pharma A/S shares decreased -1.08% to $21.96 today. Since SMA100d and SMA200d crossed up on April, ZEAL price climbed $3.66 per share (20.00%). On July/2, ZEAL hit new all time highs, pushing higher previous ATH of $22.22 recorded on May. New ATHs are usual entry points for many trading setups as there aren't higher resistences. Since price and SMA200d lines crossed up on February, ZEAL climbed $7.66 (53.57%).

ZEAL stock chart (daily)

Weekly outlook

Zealand Pharma A/S shares depreciated -1.08% this week, ending at $21.96.

Zealand Pharma A/S stock is drawing an uptrend with rising tops and bottoms. Now trading in between its last bottom and last top, ZEAL might consolidate in a flat-base, waiting to break out over or down under . Not so far away is the last price record Zealand Pharma A/S marked early July. Since SMA20d and SMA40w crossed up early April, ZEAL price climbed $2.79 per share (14.55%). Since price and SMA40w lines crossed up late January, ZEAL climbed $7.92 (56.41%).

ZEAL stock chart (weekly)

ZEAL stock price history

ZEAL IPO was on August 9th, 2017 at $18.12 per share1. Since then, ZEAL stock surged a 21.20%, with an average of 21.20% per year. If you had invested right after ZEAL's IPO a $1,000 in ZEAL stock in 2017, it would worth $212.00 today.

1: Adjusted price after possible price splits or reverse-splits.

ZEAL stock historical price chart

ZEAL stock reached all-time highs on July/2 with a price of $23.04.

ZEAL stock price target is $29.00

How much a stock will be priced tomorrow or next week is quite unpredictable However, many stock price predictions are published every day by banks, financial institutions and independent analysts. We do not recommend to follow these stock price predictions without a critical thinking from your side, as their accuracy is usually low. For the last month we only found 1 price target for Zealand Pharma A/S stock:
ZEAL stock price predictions
DateAnalyst / BrokerActionPrevious targetCurrent targetDiff
2019-3-7Needham & Company LLCReiteratesn/a$29.00-
(in average)$0.00$29.000.0%

Financials and fundamental analysis

Earnings date and Earnings per Share

On March, Zealand Pharma A/S didn't meet the estimates of the experts and posted a rough EPS of $-0.61 per share when experts were expecting $-0.69.
ZEAL earnings date and EPS evolution
QuarterReporting dateEstimated EPSActual EPSSurprise

Annual financial results

Compared to 2017, last anual sales report draw a spooky drop down of -72.14% to $37.98 million USD. Nevertheless, its earnings margin (compared to sales) climbed to 1,530.62%, that is $581.28 million.

ZEAL annual Sales and Income evolution
2013$6.57 M-$-183.68 M-2795.7%-
2014$154 M2,240.53%$-64.99 M-42.3%-64.62%
2015$188 M22.05%$-113.96 M-60.7%75.35%
2016$235 M25.10%$-153.91 M-65.6%35.06%
2017$136 M-41.94%$-275.26 M-201.9%78.84%
2018$38 M-72.14%$581 M1530.6%-311.18%

Quarterly financial results

Zealand Pharma A/S posted $13.12 million in revenues for 2018-Q4, a inf% improvement compared to previous quarter. Reported quarter income marked $-122.97 M with a profit margin of -937.37%. Profit margin stayed constant a 0.00% compared to previous quarter when profit margin was inf%. When comparing sales to same quarter last year, Zealand Pharma A/S sales marked a super good gain and skyrocketed a 24.67%.
ZEAL quarterly Sales and Income evolution
2017-Q1$78 M-$-26 M-33.9%-
2017-Q2$11 M-86.09%$-94 M-867.4%255.79%
2017-Q3$6 M-41.44%$-7 M-105.5%-92.88%
2017-Q4$11 M66.39%$-111 M-1051.6%1,559.25%
2018-Q1$11 M2.91%$-91 M-844.1%-17.40%
2018-Q2$15 M39.77%$-127 M-840.1%39.12%
2018-Q4$13 M-13.33%$-123 M-937.4%-3.29%

Zealand Pharma A/S ownership

When you are planning to invest in shares of a company, it's always worth to review its ownership structure.

Zealand Pharma A/S shares owned by insiders (that is, founders, CEO, CTO, main executives or other management staff) currently counts a 0.00% of all shares.

In case of Zealand Pharma A/S stock, 9.00% of its shares are held by institutions (mutual funds, pension funds, big banks and other large financial institutions). Bearish positions for ZEAL stock account 0.00%, no big difference from last month.

For a better understanding, the next table shows ownership data compared to other related stocks:

Market cap$675.3 M
Total shares30.8 M
Float shares27.3 M
  - Institutional holdings (%)9.0%
  - Insider holdings (%)0.0%
Shares in short selling0.0%

ZEAL summary

Monday, July 15th, 2019
Day range$21.96 - $22.19
Previous close$22.20
Session gain-1.08%
Average true range$0.47
50d mov avg$21.02
100d mov avg$18.79
200d mov avg$16.41
Daily patternlt01a
Weekly pattern lt06a

Zealand Pharma A/S performance

Performance as an absolute value is never valid if it's not benchmarked against competitors or related stocks in the industry. We compared Zealand Pharma A/S against in the following table:

Zealand Pharma A/S competitors

Unfortunately, we could not find any public company that could be defined as Zealand Pharma A/S competitor. This doesn't mean Zealand Pharma A/S does not have any competitor in the market, it's just we could not detected it.